NCT06804798

Brief Summary

This is a prospective single blinded randomized trial to evaluate the incidence of catheter associated urinary tract infection (CAUTI) between latex catheter and metal alloy coated catheter among Intensive Care Unit (ICU) patients. CAUTI has a few definitions, in this study, we will follow the latest Central of Disease Control (CDC) guideline definition of CAUTI in January 2022. This study involves 100 patients who meet the inclusion and exclusion criteria that have been set. The patients will be divided into group A and group B and two types of catheters will be given out to the healthcare workers according to the randomization. Data collection involves demographic, medical and laboratory data and will be documented in the tables provided. All data will be collected from day of urinary catheterization in ICU until patients discharge or die or maximum of 14 days in ICU or develop CAUTI or ABUTI or whichever that occurred earlier. Patients who died within 48 hours of catheter insertion, will be considered as drop-out. Data that has been extrapolated from this study will then give us an insight regarding the best type of catheter to avoid CAUTI, risk factors associated with CAUTI and to determine length of ICU stay and ICU morbidity with patients who have CAUTI. This study proves to be important in reducing the overall healthcare associated infection in the ICU setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P25-P50 for phase_4 sepsis

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
Last Updated

February 3, 2025

Status Verified

January 1, 2025

Enrollment Period

1.3 years

First QC Date

January 17, 2025

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To Compare

    To compare catheter associated urinary tract infections rate between conventional latex urinary catheter and latex metal alloy

    2 years

Secondary Outcomes (5)

  • To compare

    2 years

  • To compare

    2 years

  • To compare

    2 years

  • To compare

    2 years

  • Length of stay

    2 years

Study Arms (2)

Conventional latex urinary catheter

ACTIVE COMPARATOR
Device: Latex metal alloy coated catheter

Latex metal alloy coated catheter

EXPERIMENTAL
Device: conventional latex urinary catheter

Interventions

Metal alloy works as an antiseptic whereby preventing the attachment of biofilm to the catheter lining.

Conventional latex urinary catheter

Latex catheters prove to be soft, flexible, inexpensive and thermo-sensitive towards body temperature. However, there is a risk of developing CAUTI as bacteria are more susceptible to adhere to latex.

Latex metal alloy coated catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult more than 18 years old

You may not qualify if:

  • \. Community urosepsis 2. Chronic kidney disease and end stage renal failure 3. Suprapubic catheter 4. Patient with dependent urinary catheter 5. Pregnant ladies 6. Congenital urinary tract abnormality 7. Surgical procedure involving urinary tract 8. Moribound patient or expected to die within 24 hours 9. Discharged to ward within 48 hours 10. Latex allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia

Bandar Tun Razak, Kuala Lumpur, 56000, Malaysia

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The interventional study is between urinary catheter and conventional latex urinary catheter and metal alloy coated urinary catheter
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

January 17, 2025

First Posted

February 3, 2025

Study Start

March 1, 2023

Primary Completion

July 1, 2024

Study Completion

November 1, 2024

Last Updated

February 3, 2025

Record last verified: 2025-01

Locations